Skip to main content
. Author manuscript; available in PMC: 2012 May 3.
Published in final edited form as: Cardiol J. 2011;18(4):352–363.

Table 1.

Types of anti-pro-atherothrombogenic molecules in endothelium

Anti-atherothrombogenic Mediators Pro-atherothrombogenic Mediators
Cell Surface
Molecules
Thrombomodulin
Protein C
Heparin and Heparan sulfate
Ectonucleotidases
Tissue Factor Pathway Inhibitor
Endothelial Estrogen Receptor-alpha
(ERα)
Tissue Factor
Binding Sites for coagulation factors
Released Molecules Nitric Oxide
Prostacyclin
Tissue Plasminogen Activator (t-PA)
t-PA binding sites
Thromboxane A2
Platelet Activating Factor
Von Willebrand Factor
Endothelin

ERα plays key role in the E2-induced prevention of endothelial dysfunction after ischemia/reperfusion (60)